KSI vs. VHI, CARE, RHT, ADK, DOC, ZMD, EKG, CNNA, CARE.TO, and UDOC
Should you be buying kneat.com stock or one of its competitors? The main competitors of kneat.com include Vitalhub (VHI), Dialogue Health Technologies (CARE), Reliq Health Technologies (RHT), DIAGNOS (ADK), CloudMD Software & Services (DOC), ZoomMed (ZMD), CardioComm Solutions (EKG), Cann American (CNNA), Dialogue Health Technologies (CARE.TO), and Unidoc Health (UDOC). These companies are all part of the "health information services" industry.
kneat.com vs. Its Competitors
kneat.com (TSE:KSI) and Vitalhub (TSE:VHI) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, earnings, valuation, institutional ownership, media sentiment and risk.
Vitalhub has a net margin of 5.11% compared to kneat.com's net margin of -17.59%. Vitalhub's return on equity of 3.01% beat kneat.com's return on equity.
13.0% of kneat.com shares are owned by institutional investors. Comparatively, 32.4% of Vitalhub shares are owned by institutional investors. 26.0% of kneat.com shares are owned by company insiders. Comparatively, 18.6% of Vitalhub shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
kneat.com has a beta of 1.08, indicating that its stock price is 8% more volatile than the S&P 500. Comparatively, Vitalhub has a beta of 1.26, indicating that its stock price is 26% more volatile than the S&P 500.
In the previous week, Vitalhub had 15 more articles in the media than kneat.com. MarketBeat recorded 16 mentions for Vitalhub and 1 mentions for kneat.com. kneat.com's average media sentiment score of 0.75 beat Vitalhub's score of 0.13 indicating that kneat.com is being referred to more favorably in the media.
kneat.com currently has a consensus price target of C$6.00, indicating a potential downside of 0.99%. Vitalhub has a consensus price target of C$13.25, indicating a potential upside of 20.56%. Given Vitalhub's higher probable upside, analysts clearly believe Vitalhub is more favorable than kneat.com.
Vitalhub has higher revenue and earnings than kneat.com. kneat.com is trading at a lower price-to-earnings ratio than Vitalhub, indicating that it is currently the more affordable of the two stocks.
Summary
Vitalhub beats kneat.com on 12 of the 17 factors compared between the two stocks.
Get kneat.com News Delivered to You Automatically
Sign up to receive the latest news and ratings for KSI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding KSI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
kneat.com Competitors List
Related Companies and Tools
This page (TSE:KSI) was last updated on 6/27/2025 by MarketBeat.com Staff
Buy KSI Stock Free KSI Stock Alerts